DCF — RARITAN BAY MEDICAL CENTER
Enterprise Value: $-8.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-8.5M
Enterprise Value
$-9.9M
PV of Cash Flows
$1.5M
PV of Terminal Value
$2.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $288.2M | $6.1M | 2.0% | $-6.1M | $-5.5M |
| Year 2 | $296.8M | $9.3M | 3.0% | $-3.7M | $-3.1M |
| Year 3 | $305.7M | $12.6M | 4.0% | $-1.6M | $-1.2M |
| Year 4 | $314.9M | $14.6M | 5.0% | $-0.4M | $-0.3M |
| Year 5 | $324.3M | $15.8M | 5.0% | $0.2M | $0.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-8.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$279.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.01631230770328417
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5